Clinical Trial Update: PENNVAX-B With or Without IL-12 or IL-15 as a DNA Vaccine for HIV Infection [Phase 1]

View source ↗

Summary

Phase 1 clinical trial of PENNVAX-B DNA vaccine for HIV infection completed, evaluating vaccine with or without IL-12 or IL-15 co-administration.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection

Drugs mentioned

• Interleukin-12 (interleukin-12)
• Interleukin-15 (interleukin-15)
• PENNVAX-B (PENNVAX-B DNA vaccine)

Snippet

Sponsor: University of Pennsylvania | Conditions: HIV Infection | Phase 1 | Status: COMPLETED